AbbVie
ABBV
#29
Rank
S$568.29 B
Marketcap
S$321.65
Share price
-2.51%
Change (1 day)
27.88%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): S$7.65 Billion

According to AbbVie's latest financial reports the company's current earnings are S$62.81 Billion. In 2025 the company made an earning of S$8.45 Billion, an increase over its 2024 earnings that were of S$4.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$7.65 B-9.46%
2025 S$8.45 B77.53%
2024 S$4.76 B-40.54%
2023 S$8.01 B-53.62%
2022 S$17.27 B3.76%
2021 S$16.64 B282.25%
2020 S$4.35 B-59.67%
2019 S$10.80 B62.13%
2018 S$6.66 B-32.74%
2017 S$9.90 B-1.99%
2016 S$10.10 B18.65%
2015 S$8.51 B180.5%
2014 S$3.03 B-55.57%
2013 S$6.83 B-6.86%
2012 S$7.33 B56.05%
2011 S$4.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.57 B 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.89 B 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.64 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.08 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$13.75 B 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.30 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.79 B 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.83 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.02 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA